Michael Grissinger
Angel · Washington
Verified active in the last 12 months
Board director at 2 startups that filed Form D raises since late 2024, mostly in Washington.
- Stages
- Seed
- Typical check (est.)
- Not disclosed
- Latest fund
- None on file
- Last verified activity
- Dec 2025
Focus
Biotech & PharmaRecent portfolio activity
Sources
- SEC Form D: NephroDI TherapeuticsJun 18, 2024
- SEC Form D: Aprea TherapeuticsDec 29, 2025
Profile last verified Oct 12, 2026. Is this you? Correct or remove this profile.